How should chronic medical therapies be altered with the onset of end-stage renal disease and initiation of dialysis?
Wyne
Kathleen L
KL
Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390-8857, USA. Kathleen.Wyne@UTSouthwestern.edu
Fishbane
Steven
S
Block
Geoffrey A
GA
Warburton
Karen
K
Berns
Jeffrey S
JS
Neu
Alicia M
AM
Warady
Bradley A
BA
D002908:Chronic Disease; D003928:Diabetic Nephropathies / Q000628:therapy; D018450:Disease Progression; D050171:Dyslipidemias / Q000150:complications / Q000188:drug therapy; D006801:Humans; D007674:Kidney Diseases / Q000150:complications / Q000628:therapy*; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy*; D006435:Renal Dialysis